The Immune Response of Carbon-based Nano Light Vaccines to SARS-CoV-2

Authors

  • Qiang Wang Gansu Medical College, Pingliang 744000, China.
  • Fenfen Zhang Gansu Medical College, Pingliang 744000, China.
  • Jianshe Yang Gansu Medical College, Pingliang 744000, China and Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China.

DOI:

https://doi.org/10.9734/bpi/mono/978-81-19039-63-0/CH10

Keywords:

SARS-CoV-2, vaccines, carbon nanotube, immune response

Abstract

Elucidating the panoramic mechanism of coronavirus-host immune interaction is a strategy for disease surveillance, diagnosis, treatment, prevention, and immunity assessment of COVID-19. A robust carbon-based nano light vaccine technology system contributes to achieving the core scientific issues of this strategy. In this review, we state the latest prevention and control strategy of carbon-based nano light vaccine, and their broad-spectrum resistance to high transmissible and pathogenic variants. Furthermore, we cover the immune response to SARS-CoV-2 under carbon-based nano light vaccine intervention, and finally evaluate the efficacy of carbon-based nano light vaccines and their interactive mechanisms. The search for highly efficient, conserved T cell epitopes provide a basis for development of a new generation of T cell vaccine.

Published

2023-02-09

How to Cite

Qiang Wang, Fenfen Zhang, & Jianshe Yang. (2023). The Immune Response of Carbon-based Nano Light Vaccines to SARS-CoV-2. Diagnostic and Treatment Advances in COVID-19 and SARS-CoV-2, 147–155. https://doi.org/10.9734/bpi/mono/978-81-19039-63-0/CH10